NCT07641361

Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy

Recruiting
NAAges 18–60InterventionalTreatment
State University of New York at Buffalo
~30 participants
Updated 2026-06-11 on ClinicalTrials.gov
What's tested:Hydration PlusControl

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acceptability of hydration plus
Measured over At week 16, which is the end of the program.
+3 more outcomes measured
Obesity & Overweight
Type 2 Diabetes
Type 2 Diabetes (Adult Onset)
Obesity Type 2 Diabetes Mellitus
Dehydration
1 sites across 1 states
New York1
  • Katherine N Balantekin, PhD, RD · PRINCIPAL_INVESTIGATOR · University at Buffalo
  • Elizabeth G Mietlicki-Baase, PhD · PRINCIPAL_INVESTIGATOR · University at Buffalo
  • Leonard H Epstein, PhD · PRINCIPAL_INVESTIGATOR · University at Buffalo

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults aged 18-60
Recently prescribed a GLP-1RA (within one week of prescription)
Fluent in English
Willing to complete the study protocol

Exclusion

Children and adults \> 60 years of age
Those not taking a GLP-1RA
Those who have been on a GLP-1RA longer than one week
Not fluent in English
Those who are pregnant or planning on becoming pregnant during the duration of the study
Unwilling to comply with study protocol
People with cardiac implants
  • Acceptability of hydration plusAt week 16, which is the end of the program.

    Participants will complete a questionnaire measuring acceptability of the program. This will be on a 5 point scale, from 0 meaning completely unacceptable (worse outcome) to 5 meaning completely acceptable (better outcome).

  • Feasibility of InterventionAt week 16, which is the end of the program.

    Feasibility will be measured through participant completion of study related tasks. Scores will span from 0 to 100, with 0 meaning completed no study procedures (worse outcome) to 100 meaning completed all study procedures (better outcome).

  • Change in physiological hydration scoreBaseline (week 0) to week 16 (post - program)

    Hydration level will be measured throughout the study using multiple measurements including amount of water consumed from their Bluetooth water bottle, reported non - water beverages on MyNetDiary, urine specific gravity, and urine color will be assessed for hydration biomarkers. Blood will be drawn to assess hydration biomarkers. These are all individual measures of hydration that provide a broader image of hydration. These measures will be combined to create a general hydration score. Scores will range from 0 (hydrated, better outcome) to 10 (dehydrated, worse outcome). Changes from baseline to end of program will be assessed.

  • Change in perceived hydration levelWeek -1 (run - in week) to week 16 (end of program)

    Perceived hydration will be measured through self-reported questionnaires. The thirst scale, thirst sensation scale, and modified perception of thirst scale are validated questionnaires meant to assess thirst level, sensations associated with them, and individual perception of thirst. These surveys will be administered remotely. Survey data will be combined to create one overall perceived hydration score. Scores can range from 1 (meaning not dehydrated, better outcome) to 119 (meaning extremely dehydrated, worse outcome). Changes from the run - in week to end of program will be assessed.